Keeping Your Muscles Strong as You Age
Nov 1 2026
A grocery bag becomes a two-handed operation. A low chair starts looking like a practical joke. These changes can be easy to dismiss as ordinary aging, but declining strength deserves attention. Sarcopenia, the progressive loss of muscle strength and muscle tissue, can threaten mobility and independence. A 2026 review explains why preserving muscle involves an entire biological system, and why exercise and adequate nutrition remain its most useful maintenance tools. [1]
The paper, by Thanh T. Nguyen and colleagues, is a review of existing research, rather than a new treatment experiment. Its value is the connections it makes among energy production, nerves, inflammation, protein turnover, and muscle repair. Biology has supplied an impressive list of possible drug targets. It has been considerably less cooperative about supplying treatments that help people get out of that chair. [1]
Strength tells us more than size
Modern diagnostic guidance puts weakness near the beginning of the investigation. In the European consensus framework, low strength indicates probable sarcopenia; reduced muscle quantity or quality confirms it, and poor physical performance indicates greater severity. Clinicians may use grip strength, chair-rise tests, body-composition measurements, and walking assessments. [2]
This matters because muscle size and muscle performance can diverge. Fat can accumulate within muscle, nerve connections can deteriorate, and the remaining fibers may produce less useful force. A bathroom scale is spectacularly uninterested in these distinctions. Changes in weight alone cannot tell you whether your muscles are working well. [1]
Nor does difficulty climbing stairs automatically establish sarcopenia. Arthritis, heart or lung disease, neurological conditions, and other problems can impair the same activities. Persistent decline merits assessment rather than a self-diagnosis based on the stairs' increasingly hostile personality. [1]
The machinery behind muscle aging
Muscle is continuously rebuilding itself. Dietary amino acids supply raw materials; loading a muscle helps signal that investment in new proteins is worthwhile. One important coordinator is mTOR, a cellular signaling system that helps regulate protein synthesis. Aging can weaken the building response to food and activity, a phenomenon called anabolic resistance. [1]
Meanwhile, damaged proteins must be removed. Cells use the proteasome, a protein-disposal complex, and autophagy, a process that delivers cellular material for breakdown and recycling. Healthy muscle needs both construction and cleanup. Suppressing all breakdown would be rather like improving a kitchen by prohibiting anyone from emptying the garbage. [1]
Mitochondria add another complication. These structures help convert fuel into ATP, the molecule that powers contraction and much cellular work. Aging can impair mitochondrial performance and the removal of damaged mitochondria. NAD+, a molecule involved in energy metabolism and other cellular processes, has attracted particular interest. These mechanisms identify research opportunities; they do not establish that buying a mitochondrial supplement restores an aging muscle. [1]
Then there is the wiring. Motor nerves activate muscle fibers, and aging can disrupt those connections. Fast-twitch fibers, important for rapid force production, are especially vulnerable. The consequences may become apparent when someone needs to catch a stumble, an event that rarely provides time for a thoughtful consultation with the leg muscles. [1]
Muscle's resident stem cells, called satellite cells, also participate in repair. A 2024 human muscle atlas examined more than 180,000 cells and nuclei from 17 donors and found age-related changes in stem cells, muscle fibers, immune populations, and supporting tissues. That is evidence of a changing cellular neighborhood, not proof that one discovered pathway causes every person's weakness. The small donor sample and observational comparisons matter. [3]
Inflammation depends on the circumstances
Persistently elevated inflammatory signals can encourage protein breakdown and interfere with rebuilding. Illness, excess visceral fat, and dysfunctional cells can help sustain that environment. Yet treating every inflammatory molecule as an enemy would get the biology wrong. [1]
Contracting muscle releases signaling proteins called myokines. One, interleukin-6, can help coordinate fuel use during exercise, even though chronically elevated interleukin-6 is associated with harmful inflammatory states. The source, timing, and duration of a signal change its meaning. A brief fire drill and a fire alarm that never switches off have rather different effects on a building. [4][1]
Muscle also helps handle glucose and communicates with other organs. Preserving its function therefore belongs in a discussion of healthy longevity. But better glucose handling, a favorable blood marker, or stronger legs does not by itself demonstrate a longer human lifespan. Maintaining the ability to move independently is already a substantial outcome. [1][4]
Why promising treatments need demanding tests
Myostatin and related signals limit muscle growth. Blocking their activity is an attractive strategy, but increasing lean mass has not reliably translated into better performance. In a randomized trial of 180 older adults with sarcopenia, bimagrumab increased lean body mass more than placebo without significantly improving the primary physical-performance outcome. Both groups received nutritional support and home exercise. [5]
The lesson is uncomfortable for anyone selling a single biological shortcut. A larger engine does not necessarily fix faulty wiring, poor fuel delivery, or damaged transmission. Trials must measure what patients can actually do, alongside what their scans show.
NAD+ research offers a similar caution. In a small crossover trial, 12 older men received nicotinamide riboside or placebo. Supplementation altered the muscle NAD+ metabolome, but did not improve mitochondrial bioenergetics. The trial lasted only three weeks, so it neither settles every question about longer use nor supports claims of established muscle rejuvenation. [6]
Urolithin A, studied partly for its effects on mitochondrial recycling, illustrates mixed results. A four-month trial of 66 older adults found improvements in selected muscle-endurance tests at two months, but no significant advantage over placebo in the primary walking-distance and ATP-production outcomes. Encouraging secondary findings deserve further testing; they do not turn a supplement into proven treatment for sarcopenia. [7]
The review also discusses therapies aimed at senescent cells, which can release inflammatory signals, and approaches involving hormones, the microbiome, and regenerative pathways. Much remains experimental. The review reported no approved drug specifically for sarcopenia at publication. [1]
How you may be able to benefit
The practical priority is to give muscle a repeated reason to remain useful. Progressive resistance exercise means gradually increasing a tolerable challenge, using weights, machines, resistance bands, or appropriately adapted body-weight movements. Walking remains valuable, but a complete activity plan also includes strengthening and balance. CDC guidance recommends muscle-strengthening activity at least twice weekly for older adults, alongside aerobic and balance activity, adapted to ability and health conditions. [8]
There is evidence for meaningful functional benefit. In the SPRINTT trial, exercise plus nutritional counseling reduced mobility disability among participants with greater baseline functional impairment: 46.8% developed disability versus 52.7% receiving healthy-aging education during follow-up. This was a combined intervention in a specific vulnerable population, not proof that a particular exercise routine prevents disability in everyone. [9]
Nutrition supplies the material that training asks muscle to use. The PROT-AGE expert group recommends roughly 1.0-1.2 grams of protein per kilogram of body weight daily for many adults over 65, with individual needs varying. For someone weighing 70 kilograms, that is about 70-84 grams. Kidney disease can change the appropriate target substantially, so these numbers require individual interpretation. [10]
Useful food sources include beans, lentils, soy foods, dairy, eggs, fish, and other suitable protein-rich foods. Adequate total food intake matters too; persistent under-eating makes rebuilding harder. A dietitian can help when appetite, swallowing difficulties, dietary restrictions, or illness complicate intake. The evidence supports adequate nutrition, not a uniquely ideal anti-aging menu. [1][10]
Seek assessment if ordinary tasks are becoming steadily harder, particularly after hospitalization or unintended weight loss. Track meaningful changes in walking, rising from a chair, or carrying groceries rather than chasing a single biomarker. [1][2] The goal is a body that keeps participating in your life. Being able to stand up and get on with the day is an excellent reason to care about biochemistry.
References
[1] Nguyen TT, Dao T, Nguyen HT, et al. Sarcopenia and Muscle Aging: Updated Insights into Molecular Mechanisms and Translational Therapeutics. Endocrinol Metab (Seoul). 2026;41(1):57-85. doi:10.3803/enm.2025.2656.
[2] Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. doi:10.1093/ageing/afy169.
[3] Kedlian VR, Wang Y, Liu T, et al. Human skeletal muscle aging atlas. Nat Aging. 2024;4(5):727-744. doi:10.1038/s43587-024-00613-3.
[4] Hoffmann C, Weigert C. Skeletal Muscle as an Endocrine Organ: The Role of Myokines in Exercise Adaptations. Cold Spring Harb Perspect Med. 2017;7(11):a029793. doi:10.1101/cshperspect.a029793.
[5] Rooks D, Swan T, Goswami B, et al. Bimagrumab vs Optimized Standard of Care for Treatment of Sarcopenia in Community-Dwelling Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2020;3(10):e2020836. doi:10.1001/jamanetworkopen.2020.20836.
[6] Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide Riboside Augments the Aged Human Skeletal Muscle NAD+ Metabolome and Induces Transcriptomic and Anti-inflammatory Signatures. Cell Rep. 2019;28(7):1717-1728.e6. doi:10.1016/j.celrep.2019.07.043.
[7] Liu S, D'Amico D, Shankland E, et al. Effect of Urolithin A Supplementation on Muscle Endurance and Mitochondrial Health in Older Adults: A Randomized Clinical Trial. JAMA Netw Open. 2022;5(1):e2144279. doi:10.1001/jamanetworkopen.2021.44279.
[8] Centers for Disease Control and Prevention. Older Adult Activity An Overview. Updated December 4, 2025. Accessed October 4, 2026.
[9] Bernabei R, Landi F, Calvani R, et al. Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project). BMJ. 2022;377:e068788. doi:10.1136/bmj-2021-068788.
[10] Bauer J, Biolo G, Cederholm T, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-559. doi:10.1016/j.jamda.2013.05.021.
